Glaucoma, Primary Open Angle

Ophthalmology
1
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Bausch + Lomb
Bausch + LombNJ - Bridgewater
1 program
1
WB007 0.05%Phase 1/21 trial
Active Trials
NCT04149899Completed77Est. Dec 2022
Elios Therapeutics
2 programs
ELIOS ProcedureN/A1 trial
ELIOS ProcedureN/A1 trial
Active Trials
NCT04899063CompletedEst. Jul 2025
NCT05999006RecruitingEst. Apr 2026
S
SantenCA - Emeryville
1 program
LatanoprostN/A1 trial
Active Trials
NCT04737928Completed1Est. Jan 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bausch + LombWB007 0.05%
Elios TherapeuticsELIOS Procedure
Elios TherapeuticsELIOS Procedure
SantenLatanoprost

Clinical Trials (4)

Total enrollment: 78 patients across 4 trials

NCT04149899Bausch + LombWB007 0.05%

Safety and IOP-Lowering Effects of WB007

Start: Nov 2019Est. completion: Dec 202277 patients
Phase 1/2Completed
NCT05999006Elios TherapeuticsELIOS Procedure

Safety and Feasibility of the ELIOS System in POAG Patients

Start: Oct 2023Est. completion: Apr 2026
N/ARecruiting
NCT04899063Elios TherapeuticsELIOS Procedure

Excimer Laser Trabeculostomy Glaucoma Treatment Study

Start: May 2021Est. completion: Jul 2025
N/ACompleted
NCT04737928SantenLatanoprost

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)

Start: Apr 2018Est. completion: Jan 20191 patients
N/ACompleted

Related Jobs in Ophthalmology

Lead Data Manager

Genomics
Remote
8h ago

Cleanroom and Laboratory Technician

SAB BIO
8h ago

APAC Regulatory Affairs Manager

Johnson & Johnson
Singapore, Singapore
Yesterday

Clinical Operations Manager

Johnson & Johnson
Irvine, California, United States of America
Yesterday
$117K - $201K/yr

Site Delivery Leader MLL

Johnson & Johnson
Gent, East Flanders, Belgium
Yesterday

BM 喀什 PSR HY

Johnson & Johnson
Urumqi, Xinjiang, China
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 78 patients
3 companies competing in this space

Related Indications

Myopia(127)Cataract(116)Open-Angle Glaucoma(102)Glaucoma(92)Dry Eye(74)Age-Related Macular Degeneration(73)Dry Eye Disease(43)Neovascular Age-related Macular Degeneration(40)Macular Degeneration(37)Diabetic Retinopathy(25)